|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 26494 |
FusionGeneSummary for PDIA4_FAR1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PDIA4_FAR1 | Fusion gene ID: 26494 | Hgene | Tgene | Gene symbol | PDIA4 | FAR1 | Gene ID | 9601 | 84188 |
| Gene name | protein disulfide isomerase family A member 4 | fatty acyl-CoA reductase 1 | |
| Synonyms | ERP70|ERP72|ERp-72 | MLSTD2|PFCRD|SDR10E1 | |
| Cytomap | 7q36.1 | 11p15.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein disulfide-isomerase A4ER protein 70ER protein 72endoplasmic reticulum resident protein 70endoplasmic reticulum resident protein 72protein disulfide isomerase related protein (calcium-binding protein, intestinal-related)protein disulfide isom | fatty acyl-CoA reductase 1male sterility domain-containing protein 2short chain dehydrogenase/reductase family 10E, member 1 | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | P13667 | Q8WVX9 | |
| Ensembl transtripts involved in fusion gene | ENST00000286091, | ENST00000354817, ENST00000527202, ENST00000532502, | |
| Fusion gene scores | * DoF score | 11 X 8 X 6=528 | 28 X 8 X 12=2688 |
| # samples | 11 | 31 | |
| ** MAII score | log2(11/528*10)=-2.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(31/2688*10)=-3.11619301750452 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: PDIA4 [Title/Abstract] AND FAR1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | FAR1 | GO:0008611 | ether lipid biosynthetic process | 24108123 |
| Tgene | FAR1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process | 15220348 |
| Tgene | FAR1 | GO:0046474 | glycerophospholipid biosynthetic process | 20071337 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | CESC | TCGA-C5-A1ML-01A | PDIA4 | chr7 | 148700154 | - | FAR1 | chr11 | 13744912 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000286091 | ENST00000354817 | PDIA4 | chr7 | 148700154 | - | FAR1 | chr11 | 13744912 | + |
| 5CDS-intron | ENST00000286091 | ENST00000527202 | PDIA4 | chr7 | 148700154 | - | FAR1 | chr11 | 13744912 | + |
| 5CDS-intron | ENST00000286091 | ENST00000532502 | PDIA4 | chr7 | 148700154 | - | FAR1 | chr11 | 13744912 | + |
Top |
FusionProtFeatures for PDIA4_FAR1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PDIA4 | FAR1 |
| Catalyzes the reduction of saturated and unsaturated C16or C18 fatty acyl-CoA to fatty alcohols (PubMed:15220348,PubMed:24108123). It plays an essential role in the production ofether lipids/plasmalogens which synthesis requires fatty alcohols(PubMed:20071337, PubMed:24108123). In parallel, it is alsorequired for wax monoesters production since fatty alcohols alsoconstitute a substrate for their synthesis (By similarity).{ECO:0000250|UniProtKB:Q922J9, ECO:0000269|PubMed:15220348,ECO:0000269|PubMed:20071337, ECO:0000269|PubMed:24108123}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PDIA4_FAR1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PDIA4_FAR1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| PDIA4 | EIF2B1, VWF, APOB, H2AFX, GADD45G, BCL2L1, ELAVL1, SIRT7, CDK2, P4HB, NENF, ILF3, CDH2, LDLR, PDIA3, ERO1L, ERO1LB, ATF2, PARK2, ASNS, CAPN2, MSN, NAE1, PAFAH1B1, PAFAH1B2, ALDH7A1, CAPNS1, GSS, HMGB3, ISOC1, STK26, MYO1E, OGFOD1, PRCP, PTMA, STK24, TBCB, TWF2, VCL, PPP1R2, PROSC, RAP1GDS1, TATDN1, TUFM, YWHAE, YWHAH, GPX7, PCSK9, CUL7, OBSL1, CCDC8, PSMD4, NTRK1, EWSR1, TCTN2, TCTN3, CNTRL, TCTN1, PPME1, PTPRN, EMC3, EMC7, PTPRO, SOD1, EDEM3, TRIM25, BRCA1 | FAR1 | C20orf24, SLC2A4, CUL3, CUL5, ATXN1, IQCB1, PEX14, CLN3, CCDC8, EGFR, CYLD |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PDIA4_FAR1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PDIA4_FAR1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | FAR1 | C4015344 | PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER | 1 | ORPHANET;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|